CSE
PREV
LAST
0.020
CHANGE
0.000
OTC
PRVCF
FSE
18H
PreveCeutical Logo 2017
About Us
About Us
Company Overview
Founders
Board of Directors
Management Team
Advisory Board
CSE:
PREV
OTC:
PRVCF
FSE:
18H
AUS.SUB
PreveCeutical (Australia) Pty Ltd.
CSE:
PREV
OTC:
PRVCF
FSE:
18H
Pipeline
Pipeline
Cannabinoid Sol-Gel
Non-Addictive Analgesic
BSV Peptide Program
Dual Gene Therapy
CSE:
PREV
OTC:
PRVCF
FSE:
18H
Investors
Investors
Stock Information
News Releases
Presentations
Media
SEDAR Filings
CSE:
PREV
OTC:
PRVCF
FSE:
18H
contact
Contact
Contact Details
Subscribe
CSE:
PREV
OTC:
PRVCF
FSE:
18H
PreveCeutical Logo 2017
CSE:
PREV
LAST:
0.020
CHANGE:
0.000
OTC:
PRVCF
FSE:
18H
Home
About Us
Company Overview
Founders
Board of Directors
Management Team
Advisory Board
PreveCeutical (Australia) Pty Ltd.
Pipeline
Cannabinoid Sol-Gel
Non-Addictive Analgesic
BSV Peptide Program
Dual Gene Therapy
Investors
Stock Information
News Releases
Presentations
Media
SEDAR Filings
Contact
Contact Details
Subscribe
Presentations
Investors
Stock Information
News Releases
Presentations
Media
SEDAR Filings
Presentations
Document
Date
PDF Download
Corporate Deck
2024-07-02
Download
Gene Therapy D&O Deck
2024-01-30
Download
Non-addictive Analgesic Deck
2024-07-02
Download
Sign up for the latest news and updates
Sign Up
Begin typing and press enter.
Please enter a valid email address.
Begin typing and press enter.